Accentia Biopharmaceuticals, Inc., a biotechnology company, primarily discovers, develops, and commercializes immunotherapies to treat autoimmune related diseases and cancer in the United States. It operates in two segments: Biopharmaceutical Products and Services, and Specialty Pharmaceuticals. The Biopharmaceutical Products and Services segment develops late-stage biopharmaceutical products. The Specialty Pharmaceuticals segment markets and sells pharmaceutical products that are developed primarily by third-party development partners.
Acquired Companies: TEAMM Pharmaceuticals Inc.
Douglas W. CalderPhone:
324 South Hyde Park Ave., Suite 350, Tampa, Florida 33606